Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Houdayer

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Annales De Genetique|August 6, 1999
Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease traitC Houdayer, V Soupre, M Rosenberg-Bourgin, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Human Mutation|November 26, 1999
Compound SFTPB 1549C-->GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiencyM Tredano, R M van Elburg, A G Kaspers, et al.
Familial Cancer|September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanomaB Buecher, M Gauthier-Villars, L Desjardins, et al.
Breast Cancer Research and Treatment|December 14, 2017
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predispositionE Santana Dos Santos, S M Caputo, L Castera, et al.
Breast Cancer Research and Treatment|August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic testsP Pujol, D Stoppa Lyonnet, T Frebourg, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Annales De Genetique|August 6, 1999
Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease traitC Houdayer, V Soupre, M Rosenberg-Bourgin, et al.
Human Mutation|January 15, 2004
Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSFC Houdayer, M Gauthier-Villars, A Laugé, et al.
Human Mutation|November 26, 1999
Compound SFTPB 1549C-->GAA (121ins2) and 457delC heterozygosity in severe congenital lung disease and surfactant protein B (SP-B) deficiencyM Tredano, R M van Elburg, A G Kaspers, et al.
Familial Cancer|September 16, 2010
Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanomaB Buecher, M Gauthier-Villars, L Desjardins, et al.
Breast Cancer Research and Treatment|December 14, 2017
Assessment of the functional impact of germline BRCA1/2 variants located in non-coding regions in families with breast and/or ovarian cancer predispositionE Santana Dos Santos, S M Caputo, L Castera, et al.
Breast Cancer Research and Treatment|August 27, 2013
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic testsP Pujol, D Stoppa Lyonnet, T Frebourg, et al.
Oncogene|June 2, 2015
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutationsL Golmard, C Delnatte, A Laugé, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
Pageof 4